Clinical use of rifampicin during routine reporting of rifampicin susceptibilities: a lesson in selective reporting of antimicrobial susceptibility data - PubMed (original) (raw)

Clinical use of rifampicin during routine reporting of rifampicin susceptibilities: a lesson in selective reporting of antimicrobial susceptibility data

C H Steffee et al. J Antimicrob Chemother. 1997 Oct.

Abstract

Increased use of rifampicin for in-patients was noted after the laboratory began reporting rifampicin susceptibilities routinely for all Gram-positive bacterial isolates. The appropriateness of rifampicin use was evaluated by chart review for in-patients administered rifampicin during two time periods, before and during routine rifampicin susceptibility reporting, respectively. While rifampicin susceptibility was reported routinely, four patients were subjected to potentially harmful misuse of rifampicin. These findings reconfirm the necessity of interdepartmental consultation and extensive staff education whenever a modification of antimicrobial susceptibility profile reporting is contemplated. Furthermore, they underscore the role of the clinical microbiology laboratory in guiding antimicrobial therapy through limited reporting of susceptibility data.

PubMed Disclaimer

Cited by

Staphylococcus aureus - selective reporting of antibiogram results and its impact on antibiotic use: Interventional study with a reference group on the effect of switching from non-selective to selective antibiotic reporting.
Lestin-Bernstein F, Harberg R, Schumacher I, Briedigkeit L, Heese O, Biedermann K. Lestin-Bernstein F, et al. Antimicrob Resist Infect Control. 2021 Nov 6;10(1):157. doi: 10.1186/s13756-021-01021-7. Antimicrob Resist Infect Control. 2021. PMID: 34742320 Free PMC article.
Impact of selective reporting of antibiotic susceptibility test results in urinary tract infections in the outpatient setting: a protocol for a pragmatic, prospective quasi-experimental trial.
Binda F, Fougnot S, De Monchy P, Fagot-Campagna A, Pulcini C, Thilly N; ANTIBIO-CIBLÉ Scientific Committee. Binda F, et al. BMJ Open. 2019 Feb 22;8(11):e025810. doi: 10.1136/bmjopen-2018-025810. BMJ Open. 2019. PMID: 30798294 Free PMC article.
Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases.
de With K, Allerberger F, Amann S, Apfalter P, Brodt HR, Eckmanns T, Fellhauer M, Geiss HK, Janata O, Krause R, Lemmen S, Meyer E, Mittermayer H, Porsche U, Presterl E, Reuter S, Sinha B, Strauß R, Wechsler-Fördös A, Wenisch C, Kern WV. de With K, et al. Infection. 2016 Jun;44(3):395-439. doi: 10.1007/s15010-016-0885-z. Infection. 2016. PMID: 27066980 Free PMC article.
Information Complexity and Behavior Intention to Prescribe Antibiotics Based on the Antimicrobial Susceptibility Testing Report: The Mediating Roles of Information Overload and Attitude.
Wang Y, Zhang X, Zhou Q, Xu X, Liu X, Lu S. Wang Y, et al. Front Pharmacol. 2021 Nov 10;12:778664. doi: 10.3389/fphar.2021.778664. eCollection 2021. Front Pharmacol. 2021. PMID: 34899342 Free PMC article.
Antimicrobial Stewardship in the Microbiology Laboratory: Impact of Selective Susceptibility Reporting on Ciprofloxacin Utilization and Susceptibility of Gram-Negative Isolates to Ciprofloxacin in a Hospital Setting.
Langford BJ, Seah J, Chan A, Downing M, Johnstone J, Matukas LM. Langford BJ, et al. J Clin Microbiol. 2016 Sep;54(9):2343-7. doi: 10.1128/JCM.00950-16. Epub 2016 Jul 6. J Clin Microbiol. 2016. PMID: 27385708 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
Medical
- MedlinePlus Health Information

Clinical use of rifampicin during routine reporting of rifampicin susceptibilities: a lesson in selective reporting of antimicrobial susceptibility data - PubMed (original) (raw)